Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3323532
Max Phase: Preclinical
Molecular Formula: C16H16BrN7O2S2
Molecular Weight: 482.39
Molecule Type: Small molecule
Associated Items:
ID: ALA3323532
Max Phase: Preclinical
Molecular Formula: C16H16BrN7O2S2
Molecular Weight: 482.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nn1c(Cc2cccs2)nn(CC(=O)NNC(=S)Nc2ccc(Br)cc2)c1=O
Standard InChI: InChI=1S/C16H16BrN7O2S2/c17-10-3-5-11(6-4-10)19-15(27)21-20-14(25)9-23-16(26)24(18)13(22-23)8-12-2-1-7-28-12/h1-7H,8-9,18H2,(H,20,25)(H2,19,21,27)
Standard InChI Key: HQUVUGXFGZYYAS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 482.39 | Molecular Weight (Monoisotopic): 480.9990 | AlogP: 1.19 | #Rotatable Bonds: 5 |
Polar Surface Area: 119.00 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.47 | CX Basic pKa: 2.30 | CX LogP: 2.76 | CX LogD: 2.76 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.25 | Np Likeness Score: -2.73 |
1. Ünver Y, Sancak K, Çelik F, Birinci E, Küçük M, Soylu S, Burnaz NA.. (2014) New thiophene-1,2,4-triazole-5(3)-ones: highly bioactive thiosemicarbazides, structures of Schiff bases and triazole-thiols., 84 [PMID:25063946] [10.1016/j.ejmech.2014.01.014] |
Source(1):